LeMaitre Vascular (LMAT)
(Delayed Data from NSDQ)
$77.48 USD
-0.31 (-0.40%)
Updated Jun 7, 2024 04:00 PM ET
After-Market: $77.18 -0.30 (-0.39%) 7:58 PM ET
2-Buy of 5 2
C Value C Growth F Momentum D VGM
Brokerage Reports
LeMaitre Vascular, Inc. [LMAT]
Reports for Purchase
Showing records 101 - 120 ( 189 total )
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
3Q19 Recap - Solid Results; Waiting on Entry Point
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
2Q19 Recap - Upside Results Appear Priced In (Pending Acquisitions)
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
1Q19 Recap - Acquisitions Appear the Near-Term Driver
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
We are placing shares Under Review, and transferring coverage to due to the departure of the covering analyst
Provider: Roth Capital Partners, Inc.
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
We are transferring coverage, placing Under Review, and removing PT''s and estimates
Provider: Roth Capital Partners, Inc.
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
Transferring coverage with a Neutral rating, $39/share price target
Provider: Roth Capital Partners, Inc.
Analyst: SOLOMON D
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
2Q18 Recap - In Line Quarter, Near- Term Acquisition?
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
MID-DAY SUMMARY
Provider: Roth Capital Partners, Inc.
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
Growth Story Intact; Resuming with a Buy Rating, $38 PT
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
Healthcare - Coverage Update - Healthcare Sector
Provider: Roth Capital Partners, Inc.
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
We are placing shares of LMAT Under Review, and transferring coverage to Scott Henry, CFA due to the departure of the covering analyst.
Provider: Roth Capital Partners, Inc.